Dr. Jeffrey R. Jay, M.D.

Great Point Partners as of June 30, 2017

Portfolio Holdings for Great Point Partners

Great Point Partners holds 35 positions in its portfolio as reported in the June 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Arena Pharmaceuticals 7.4 $41M 2.4M 16.87
Ptc Therapeutics I (PTCT) 7.1 $40M 2.2M 18.33
Adamas Pharmaceuticals 6.9 $39M 2.2M 17.49
Vanda Pharmaceuticals (VNDA) 6.5 $36M 2.2M 16.30
Zogenix 6.3 $35M 2.4M 14.50
Synergy Pharmaceuticals 5.8 $32M 7.2M 4.45
Concert Pharmaceuticals I equity 5.0 $28M 2.0M 13.95
Neurocrine Biosciences (NBIX) 4.9 $28M 600k 46.00
Rigel Pharmaceuticals (RIGL) 4.5 $25M 9.1M 2.73
Sage Therapeutics (SAGE) 4.2 $24M 295k 79.64
Foamix Pharmaceuticals 4.0 $22M 4.8M 4.64
Alnylam Pharmaceuticals (ALNY) 4.0 $22M 277k 79.76
Selecta Biosciences (RNAC) 3.3 $19M 938k 19.86
Ignyta 3.2 $18M 1.7M 10.35
Dbv Technologies S A (DBVT) 3.2 $18M 500k 35.71
Acceleron Pharma 2.7 $15M 494k 30.39
Pacira Pharmaceuticals (PCRX) 2.6 $14M 300k 47.70
Seattle Genetics 2.3 $13M 250k 51.74
Portola Pharmaceuticals 2.2 $12M 216k 56.17
Neuroderm Ltd F 1.7 $9.3M 311k 29.90
Insmed (INSM) 1.7 $9.2M 539k 17.16
Aimmune Therapeutics 1.6 $9.0M 435k 20.56
Newlink Genetics Corporation 1.4 $8.0M 1.1M 7.35
Bovie Medical Corporation 1.3 $7.2M 2.9M 2.47
Amarin Corporation (AMRN) 1.3 $7.1M 1.8M 4.03
Global Blood Therapeutics In 1.2 $7.0M 255k 27.35
Cara Therapeutics (CARA) 0.9 $4.9M 321k 15.38
Dynavax Technologies (DVAX) 0.8 $4.2M 436k 9.65
Sunesis Pharmaceuticals Inc Ne 0.7 $3.9M 1.4M 2.70
Myovant Sciences 0.5 $2.9M 248k 11.70
Connecture 0.5 $2.6M 4.1M 0.62
Iovance Biotherapeutics (IOVA) 0.2 $1.2M 169k 7.35
Aradigm 0.1 $835k 637k 1.31
Amicus Therapeutics (FOLD) 0.0 $125k 12k 10.08
Streamline Health Solutions (STRM) 0.0 $139k 130k 1.07